US2017135970A1PendingUtilityA1
N-acetylcysteine amide (nac amide) in the treatment of diseases and conditions associated with oxidative stress
Est. expiryApr 21, 2025(expired)· nominal 20-yr term from priority
Inventors:Glenn A. Goldstein
A61K 31/16C07C 233/26A61K 31/375A61K 9/0019C07C 233/36C07C 323/60C07C 323/41C07C 233/18A61K 9/0043A61K 9/007A61K 31/167A61K 9/0014
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.
Claims
exact text as granted — not AI-modified1 - 8 . (canceled)
9 . A method of increasing levels of thiol antioxidants in an organism, comprising administering NAC amide or derivative of NAC amide to the organism in an amount effective to increase thiol antioxidant levels.
10 . The method according to claim 9 , wherein the thiol antioxidant is glutathione or cysteine.
11 . The method according to claim 9 , wherein the levels of thiol antioxidant increase in liver and plasma.
12 . The method according to claim 9 , wherein NAC amide or derivative of NAC amide is administered orally in an amount of 500 mg/kg.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.